Susquehanna International Group
SEEL

Susquehanna International Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Susquehanna International Group’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,066
Closed -$190K – 13639
2023
Q4 		$190K Buy
1,066
+1,029
+2,781% +$506K ﹤0.01% 10737
2023
Q3 		$25.9K Buy
37
+1
+3% +$4.29K ﹤0.01% 11533
2023
Q2 		$166K Buy
36
+10
+38% +$34.7K ﹤0.01% 10464
2023
Q1 		$69.2K Sell
26
-14
-35% -$41K ﹤0.01% 11534
2022
Q4 		$104K Sell
40
-1
-2% -$3.49K ﹤0.01% 10931
2022
Q3 		$162K Sell
41
-55
-57% -$216K ﹤0.01% 11136
2022
Q2 		$250K Buy
96
+5
+5% +$13K ﹤0.01% 10062
2022
Q1 		$293K Buy
91
+16
+21% +$68.8K ﹤0.01% 10334
2021
Q4 		$467K Buy
75
+28
+60% +$215K ﹤0.01% 9394
2021
Q3 		$431K Sell
47
-10
-18% -$85.9K ﹤0.01% 9764
2021
Q2 		$580K Buy
57
+44
+338% +$723K ﹤0.01% 9241
2021
Q1 		$258K Buy
+13
New +$152K ﹤0.01% 10929
2016
Q3 		– Hold
0
– -$26K – 9186
2016
Q2 		– Hold
0
– – – 8352
2016
Q1 		– Hold
0
– – – 8808
2014
Q4 		– Hold
0
– -$66K – 10193
2014
Q3 		– Hold
0
– – – 9167
2014
Q2 		– Hold
0
– – – 7946
2014
Q1 		– Hold
0
– – – 8316

Other funds holding SEEL

WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return

Susquehanna International Group's SEEL Position: Q4 2023 in Review

Susquehanna International Group sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2023, closing a stake of 27 shares — an estimated $13.3K sold.

Susquehanna International Group first reported a position in SEEL in Q3 2019 and held it in 11 quarters. The position peaked at $2.7M in Q1 2021. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.

  • Susquehanna International Group reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 27 Seelos Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $13.3K.
  • Susquehanna International Group first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
  • Susquehanna International Group's Seelos Therapeutics, Inc. Common Stock position peaked at $2.7M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.